Small Molecule Targeted Anti-Cancer Drug Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Monoclonal Antibodies, Small Molecules, Small Molecule Drug Conjugates)

Report Code: TIPRE00018839 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Over the past few years, there has been an influx of cluster of innovative cancer therapies for patients but the increased interest about the small molecule cancer drugs has brought for a wide variety of treatment types approaching a one-size-fits-all approach. The discovery of small molecule cancer drugs for cancer patients has brought a promising novel mechanism of treatment in cancer patients. Since its inception, a large number of potential novel small molecule cancer drugs have been approved and several are under clinical development or under regulatory process. Moreover, the large number of drugs under regulatory review suggest greater breakthroughs that will be assisting R&D activities among the alternative treatments available for various types of cancer.

MARKET DYNAMICS

Small Molecule Targeted Anti-cancer Drug market is driving due to factors such as increased prevalence of cancer cases and numerous benefits associated with the small molecule cancer therapy such as improved overall outcomes, minimal adverse effects, earlier treatment initiation, and small size of drugs. However, factor such as high cost and stringent regulations are expected to hamper the market growth.

MARKET SCOPE

The Small Molecule Targeted Anti-cancer Drug market analysis to 2027 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Small Molecule Targeted Anti-cancer Drug market with detailed market segmentation by Type. The Small Molecule Targeted Anti-cancer Drug market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Small Molecule Targeted Anti-cancer Drug market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Small Molecule Targeted Anti-cancer Drug market is segmented on the basis of Type. Based on Type, market is segmented as monoclonal antibodies, small molecules, small molecule drug conjugates. The monoclonal antibodies segment is further subsegmented into fully human antibody, chimeric monoclonal antibody, humanized monoclonal antibody. The small molecules segment is further subsegmented into small molecule cyclin-dependent kinase inhibitor, small molecule proteasome inhibitor, and small molecule tyrosine kinase inhibitor.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Small Molecule Targeted Anti-cancer Drug market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Small Molecule Targeted Anti-cancer Drug market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Small Molecule Targeted Anti-cancer Drug market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Small Molecule Targeted Anti-cancer Drug market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Small Molecule Targeted Anti-cancer Drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as Type launches, Type approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Small Molecule Targeted Anti-cancer Drug market are anticipated to have lucrative growth opportunities in the future with the rising demand for Small Molecule Targeted Anti-cancer Drug in the global market. Below mentioned is the list of few companies engaged in the Small Molecule Targeted Anti-cancer Drug market.

The report also includes the profiles of key players in Small Molecule Targeted Anti-cancer Drug market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- OncoGenex Pharmaceuticals, Inc.
- Cytokinetics Inc.
- Hospira Inc.
- GlaxoSmithKline plc.
- Boehringer Ingelheim GmbH
- Bayer HealthCare AG
- Abbott Laboratories.
- Allergan
- Pfizer
- Gilead Sciences
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Small Molecule Targeted Anti-Cancer Drug Market - By Type
1.3.2 Small Molecule Targeted Anti-Cancer Drug Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SMALL MOLECULE TARGETED ANTI-CANCER DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SMALL MOLECULE TARGETED ANTI-CANCER DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SMALL MOLECULE TARGETED ANTI-CANCER DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. SMALL MOLECULE TARGETED ANTI-CANCER DRUG - GLOBAL MARKET OVERVIEW
6.2. SMALL MOLECULE TARGETED ANTI-CANCER DRUG - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. SMALL MOLECULE TARGETED ANTI-CANCER DRUG MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOCLONAL ANTIBODIES
7.3.1. Overview
7.3.2. Monoclonal Antibodies Market Forecast and Analysis
7.3.3. Fully Human Antibody Market
7.3.3.1. Overview
7.3.3.2. Fully Human Antibody Market Forecast and Analysis
7.3.4. Chimeric Monoclonal Antibody Market
7.3.4.1. Overview
7.3.4.2. Chimeric Monoclonal Antibody Market Forecast and Analysis
7.3.5. Humanized Monoclonal Antibody Market
7.3.5.1. Overview
7.3.5.2. Humanized Monoclonal Antibody Market Forecast and Analysis
7.4. SMALL MOLECULES
7.4.1. Overview
7.4.2. Small Molecules Market Forecast and Analysis
7.4.3. Small Molecule Cyclin dependent Kinase Inhibitor Market
7.4.3.1. Overview
7.4.3.2. Small Molecule Cyclin dependent Kinase Inhibitor Market Forecast and Analysis
7.4.4. Small Molecule Proteasome Inhibitor Market
7.4.4.1. Overview
7.4.4.2. Small Molecule Proteasome Inhibitor Market Forecast and Analysis
7.4.5. Small Molecule Tyrosine Kinase Inhibitor Market
7.4.5.1. Overview
7.4.5.2. Small Molecule Tyrosine Kinase Inhibitor Market Forecast and Analysis
7.5. SMALL MOLECULE DRUG CONJUGATES
7.5.1. Overview
7.5.2. Small Molecule Drug Conjugates Market Forecast and Analysis
8. SMALL MOLECULE TARGETED ANTI-CANCER DRUG MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Small Molecule Targeted Anti-Cancer Drug Market Overview
8.1.2 North America Small Molecule Targeted Anti-Cancer Drug Market Forecasts and Analysis
8.1.3 North America Small Molecule Targeted Anti-Cancer Drug Market Forecasts and Analysis - By Type
8.1.4 North America Small Molecule Targeted Anti-Cancer Drug Market Forecasts and Analysis - By Countries
8.1.4.1 United States Small Molecule Targeted Anti-Cancer Drug Market
8.1.4.1.1 United States Small Molecule Targeted Anti-Cancer Drug Market by Type
8.1.4.2 Canada Small Molecule Targeted Anti-Cancer Drug Market
8.1.4.2.1 Canada Small Molecule Targeted Anti-Cancer Drug Market by Type
8.1.4.3 Mexico Small Molecule Targeted Anti-Cancer Drug Market
8.1.4.3.1 Mexico Small Molecule Targeted Anti-Cancer Drug Market by Type
8.2. EUROPE
8.2.1 Europe Small Molecule Targeted Anti-Cancer Drug Market Overview
8.2.2 Europe Small Molecule Targeted Anti-Cancer Drug Market Forecasts and Analysis
8.2.3 Europe Small Molecule Targeted Anti-Cancer Drug Market Forecasts and Analysis - By Type
8.2.4 Europe Small Molecule Targeted Anti-Cancer Drug Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Small Molecule Targeted Anti-Cancer Drug Market
8.2.4.1.1 Germany Small Molecule Targeted Anti-Cancer Drug Market by Type
8.2.4.2 France Small Molecule Targeted Anti-Cancer Drug Market
8.2.4.2.1 France Small Molecule Targeted Anti-Cancer Drug Market by Type
8.2.4.3 Italy Small Molecule Targeted Anti-Cancer Drug Market
8.2.4.3.1 Italy Small Molecule Targeted Anti-Cancer Drug Market by Type
8.2.4.4 Spain Small Molecule Targeted Anti-Cancer Drug Market
8.2.4.4.1 Spain Small Molecule Targeted Anti-Cancer Drug Market by Type
8.2.4.5 United Kingdom Small Molecule Targeted Anti-Cancer Drug Market
8.2.4.5.1 United Kingdom Small Molecule Targeted Anti-Cancer Drug Market by Type
8.2.4.6 Rest of Europe Small Molecule Targeted Anti-Cancer Drug Market
8.2.4.6.1 Rest of Europe Small Molecule Targeted Anti-Cancer Drug Market by Type
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Small Molecule Targeted Anti-Cancer Drug Market Overview
8.3.2 Asia-Pacific Small Molecule Targeted Anti-Cancer Drug Market Forecasts and Analysis
8.3.3 Asia-Pacific Small Molecule Targeted Anti-Cancer Drug Market Forecasts and Analysis - By Type
8.3.4 Asia-Pacific Small Molecule Targeted Anti-Cancer Drug Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Small Molecule Targeted Anti-Cancer Drug Market
8.3.4.1.1 Australia Small Molecule Targeted Anti-Cancer Drug Market by Type
8.3.4.2 China Small Molecule Targeted Anti-Cancer Drug Market
8.3.4.2.1 China Small Molecule Targeted Anti-Cancer Drug Market by Type
8.3.4.3 India Small Molecule Targeted Anti-Cancer Drug Market
8.3.4.3.1 India Small Molecule Targeted Anti-Cancer Drug Market by Type
8.3.4.4 Japan Small Molecule Targeted Anti-Cancer Drug Market
8.3.4.4.1 Japan Small Molecule Targeted Anti-Cancer Drug Market by Type
8.3.4.5 South Korea Small Molecule Targeted Anti-Cancer Drug Market
8.3.4.5.1 South Korea Small Molecule Targeted Anti-Cancer Drug Market by Type
8.3.4.6 Rest of Asia-Pacific Small Molecule Targeted Anti-Cancer Drug Market
8.3.4.6.1 Rest of Asia-Pacific Small Molecule Targeted Anti-Cancer Drug Market by Type
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Small Molecule Targeted Anti-Cancer Drug Market Overview
8.4.2 Middle East and Africa Small Molecule Targeted Anti-Cancer Drug Market Forecasts and Analysis
8.4.3 Middle East and Africa Small Molecule Targeted Anti-Cancer Drug Market Forecasts and Analysis - By Type
8.4.4 Middle East and Africa Small Molecule Targeted Anti-Cancer Drug Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Small Molecule Targeted Anti-Cancer Drug Market
8.4.4.1.1 South Africa Small Molecule Targeted Anti-Cancer Drug Market by Type
8.4.4.2 Saudi Arabia Small Molecule Targeted Anti-Cancer Drug Market
8.4.4.2.1 Saudi Arabia Small Molecule Targeted Anti-Cancer Drug Market by Type
8.4.4.3 U.A.E Small Molecule Targeted Anti-Cancer Drug Market
8.4.4.3.1 U.A.E Small Molecule Targeted Anti-Cancer Drug Market by Type
8.4.4.4 Rest of Middle East and Africa Small Molecule Targeted Anti-Cancer Drug Market
8.4.4.4.1 Rest of Middle East and Africa Small Molecule Targeted Anti-Cancer Drug Market by Type
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Small Molecule Targeted Anti-Cancer Drug Market Overview
8.5.2 South and Central America Small Molecule Targeted Anti-Cancer Drug Market Forecasts and Analysis
8.5.3 South and Central America Small Molecule Targeted Anti-Cancer Drug Market Forecasts and Analysis - By Type
8.5.4 South and Central America Small Molecule Targeted Anti-Cancer Drug Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Small Molecule Targeted Anti-Cancer Drug Market
8.5.4.1.1 Brazil Small Molecule Targeted Anti-Cancer Drug Market by Type
8.5.4.2 Argentina Small Molecule Targeted Anti-Cancer Drug Market
8.5.4.2.1 Argentina Small Molecule Targeted Anti-Cancer Drug Market by Type
8.5.4.3 Rest of South and Central America Small Molecule Targeted Anti-Cancer Drug Market
8.5.4.3.1 Rest of South and Central America Small Molecule Targeted Anti-Cancer Drug Market by Type
9. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SMALL MOLECULE TARGETED ANTI-CANCER DRUG MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Middle East and Africa
9.5 South and Central America
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. SMALL MOLECULE TARGETED ANTI-CANCER DRUG MARKET, KEY COMPANY PROFILES
11.1. ONCOGENEX PHARMACEUTICALS, INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. CYTOKINETICS INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. HOSPIRA INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GLAXOSMITHKLINE PLC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BOEHRINGER INGELHEIM GMBH
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BAYER HEALTHCARE AG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ABBOTT LABORATORIES
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ALLERGAN
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. PFIZER
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. GILEAD SCIENCES
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. OncoGenex Pharmaceuticals, Inc.
2. Cytokinetics Inc.
3. Hospira Inc.
4. GlaxoSmithKline plc.
5. Boehringer Ingelheim GmbH
6. Bayer HealthCare AG
7. Abbott Laboratories.
8. Allergan
9. Pfizer
10. Gilead Sciences
TIPRE00018839
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking